Skip to Content

Helix Biomedix HXBM

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Helix Biomedix is a specialty dermatology and consumer products skin health company with an extensive library of structurally diverse bioactive peptides and patents. Its intellectual property portfolio offers multiple pathways for commercialization in the area ranging from Rx dermatology to aesthetic dermatology and personal care.

22121 17th Avenue SE, Suite 112
Bothell, WA, 98021
T +1 425 402-8400
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2012
Fiscal Year End Dec 31, 2021
Stock Type Distressed
Employees 8